TOUJEO

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug TOUJEO contains one active pharmaceutical ingredient (API):

1	Insulin glargine UNII 2ZM8CX04RZ - INSULIN GLARGINE
	Insulin glargine is a human insulin analogue designed to have a low solubility at neutral pH. After injection, the acidic solution is neutralised leading to formation of a precipitate from which small amounts of insulin glargine are continuously released.
	Read more about Insulin glargine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TOUJEO Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10AE04	Insulin glargine	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AE Insulins and analogues for injection, long-acting
Discover more medicines within A10AE04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11302W, 11308E
BR	Câmara de Regulação do Mercado de Medicamentos	502816010070703, 502816010070803, 576720020055617, 576720020055717
CA	Health Products and Food Branch	02441829, 02493373
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	62-MBE-0716
EE	Ravimiamet	1202971, 1202982, 1202993, 1203006, 1203017, 1203028, 1203039, 1203040, 1483455, 1483466, 1483477, 1483488, 1483499, 1483501, 1483512, 1483523, 1483624, 1483635, 1483646, 1483657, 1483668, 1483679, 1483680, 1483691, 1483703, 1483714, 1483725, 1483736, 1483747, 1483758, 1483769, 1483770, 1684010, 1684021, 1684043, 1728794, 1806982, 1806993, 1807006, 1807017, 1807028
ES	Centro de información online de medicamentos de la AEMPS	1000133038, 100133034
FI	Lääkealan turvallisuus- ja kehittämiskeskus	479186, 577406
FR	Base de données publique des médicaments	62030744, 68378405
GB	Medicines & Healthcare Products Regulatory Agency	298670, 369114, 381706, 389915, 393611
HK	Department of Health Drug Office	64661
IE	Health Products Regulatory Authority	31145, 41752, 41753
IL	מִשְׂרַד הַבְּרִיאוּת	7862
IT	Agenzia del Farmaco	043192018, 043192020, 043192032, 043192044, 043192057, 043192069, 043192071, 043192083, 043192095, 043192107, 043192119, 043192133, 043192145, 043192158, 043192160, 043192172, 043192184, 043192196, 043192208, 043192210, 043192222, 043192234, 043192246, 043192259, 043192261, 043192273, 043192285, 043192297, 043192309, 043192311, 043192323, 043192335, 043192347, 043192350, 043192362, 043192374, 043192386, 043192398, 043192400, 043192412, 043192424
LT	Valstybinė vaistų kontrolės tarnyba	1030338, 1030339, 1030340, 1030341, 1030342, 1030343, 1030344, 1030345, 1056646, 1056647, 1056648, 1056649, 1056650, 1056651, 1056652, 1056653, 1056654, 1056655, 1056656, 1056657, 1056658, 1056659, 1056660, 1056661, 1056663, 1056664, 1056665, 1056666, 1056667, 1056668, 1056669, 1056670, 1076828, 1076829, 1076830, 1080854, 1087719, 1087720, 1087721, 1087722, 1088306
NL	Z-Index G-Standaard, PRK	125652, 197521
NZ	Medicines and Medical Devices Safety Authority	17846
PL	Rejestru Produktów Leczniczych	100340158
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W61744001, W61744002, W61744003, W65691001
SG	Health Sciences Authority	15138P
TN	Direction de la Pharmacie et du Médicament	1823041
TR	İlaç ve Tıbbi Cihaz Kurumu	8699809950856, 8699809950863
US	FDA, National Drug Code	0024-5869, 0024-5871, 50090-4177
ZA	Health Products Regulatory Authority	49/21.1/1230